Cargando…
IL‐1RA suppresses esophageal cancer cell growth by blocking IL‐1α
BACKGROUND: Interleukin‐1 promotes tumor angiogenesis through VEGF production. The interleukin‐1 receptor antagonist can suppress tumors by blocking this effect. METHODS: Immunohistochemistry, WB, and gene sequencing were used to analyze the expression of IL‐1RA in esophageal cancer patients. WB was...
Autores principales: | Chen, Sui, Shen, Zhimin, Liu, Zhun, Gao, Lei, Han, Ziyang, Yu, Shaobin, Kang, Mingqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642324/ https://www.ncbi.nlm.nih.gov/pubmed/31102307 http://dx.doi.org/10.1002/jcla.22903 |
Ejemplares similares
-
IL-1RA inhibits esophageal carcinogenesis and lymphangiogenesis via downregulating VEGF-C and MMP9
por: Shen, Zhimin, et al.
Publicado: (2023) -
TPM3 mediates epithelial-mesenchymal transition in esophageal cancer via MMP2/MMP9
por: Chen, Sui, et al.
Publicado: (2021) -
Exosome-mediated miR-25/miR-203 as a potential biomarker for esophageal squamous cell carcinoma: improving early diagnosis and revealing malignancy
por: Liu, Zhun, et al.
Publicado: (2021) -
A Brief History of IL-1 and IL-1 Ra in Rheumatology
por: Dayer, Jean-Michel, et al.
Publicado: (2017) -
Intracellular IL-1 receptor antagonist (icIL-1Ra1) does not antagonize growth inhibitory effects of pre-IL-1α in SaOS-2 cells
por: Palmer, G, et al.
Publicado: (2005)